2023
DOI: 10.1007/s00277-023-05242-1
|View full text |Cite
|
Sign up to set email alerts
|

Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles